💨 Abstract

A clinical trial comparing tirzepatide (Mounjaro) and semaglutide (Wegovy) found tirzepatide to be more effective. After 72 weeks, participants on tirzepatide saw an average 20.2% weight loss, equating to 22.8 kg, and a 7.2-inch waist reduction. Those on semaglutide experienced a 13.7%

Courtesy: theprint.in